Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122939002 | 12293900 | 2 | F | 2000 | 20160825 | 20160422 | 20160901 | EXP | US-ASTRAZENECA-2016SE41295 | ASTRAZENECA | 75.00 | YR | F | Y | 72.60000 | KG | 20160901 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122939002 | 12293900 | 1 | PS | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | 19962 | 100 | MG | MODIFIED-RELEASE TABLET | QD | |||||||
| 122939002 | 12293900 | 2 | SS | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | 19962 | 100 | MG | MODIFIED-RELEASE TABLET | QD | |||||||
| 122939002 | 12293900 | 3 | SS | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | 19962 | 100 | MG | MODIFIED-RELEASE TABLET | BID | |||||||
| 122939002 | 12293900 | 4 | SS | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | 19962 | 100 | MG | MODIFIED-RELEASE TABLET | BID | |||||||
| 122939002 | 12293900 | 5 | SS | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | 19962 | 100 | MG | MODIFIED-RELEASE TABLET | QD | |||||||
| 122939002 | 12293900 | 6 | SS | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | 19962 | 100 | MG | MODIFIED-RELEASE TABLET | QD | |||||||
| 122939002 | 12293900 | 7 | SS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Unknown | U | 0 | ||||||||||
| 122939002 | 12293900 | 8 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | U | U | 0 | |||||||||
| 122939002 | 12293900 | 9 | C | ENALIPRIL | 2 | Oral | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122939002 | 12293900 | 1 | Hypertension |
| 122939002 | 12293900 | 2 | Coronary artery disease |
| 122939002 | 12293900 | 3 | Hypertension |
| 122939002 | 12293900 | 4 | Coronary artery disease |
| 122939002 | 12293900 | 5 | Hypertension |
| 122939002 | 12293900 | 6 | Coronary artery disease |
| 122939002 | 12293900 | 8 | Gastrooesophageal reflux disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122939002 | 12293900 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122939002 | 12293900 | Diabetes mellitus | |
| 122939002 | 12293900 | Hypertension | |
| 122939002 | 12293900 | Loss of consciousness | |
| 122939002 | 12293900 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122939002 | 12293900 | 1 | 2000 | 201506 | 0 | |
| 122939002 | 12293900 | 2 | 2000 | 201506 | 0 | |
| 122939002 | 12293900 | 3 | 201511 | 201601 | 0 | |
| 122939002 | 12293900 | 4 | 201511 | 201601 | 0 | |
| 122939002 | 12293900 | 5 | 201602 | 0 | ||
| 122939002 | 12293900 | 6 | 201602 | 0 | ||
| 122939002 | 12293900 | 7 | 201601 | 0 |